Weichs, Germany

Barbara Monse


Average Co-Inventor Count = 4.2

ph-index = 3

Forward Citations = 17(Granted Patents)


Location History:

  • Castres, FR (1999 - 2000)
  • Weichs, DE (2007 - 2008)

Company Filing History:


Years Active: 1999-2008

Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovations of Inventor Barbara Monse

Introduction

Barbara Monse, a prominent inventor located in Weichs, Germany, has made significant contributions to the field of medicinal chemistry. With a robust portfolio of four patents, she stands out for her innovative approach to developing compounds aimed at treating various diseases. Her work has the potential to impact therapeutic interventions for conditions such as diabetes and neurodegenerative disorders.

Latest Patents

Among her most notable inventions is the patent for the preparation method and therapeutic uses of 3β-amino azabicyclooctane heteroaromatic amid derivatives. This invention features compounds that possess anti-dopaminergic properties, which could be pivotal in treating several neurological conditions. The compounds are characterized by a complex structure involving various nitrogen and carbon atoms, leading to unique bicyclic fused heteroaromatic compounds.

Additionally, Barbara's patent on N-carbacycle monosubstituted indolocarbazoles as protein kinase inhibitors showcases her expertise in creating medicaments that target neurodegenerative diseases and malignancies. These innovative compounds are designed for treating conditions such as non-insulin dependent diabetes mellitus, acute stroke, and Alzheimer’s disease, further illustrating her significant contributions to medical advancements.

Career Highlights

Barbara has had a successful career working with esteemed organizations such as Pierre Fabre Medicament and Nad Ag. Her experience in these environments has greatly influenced her research and patent developments, allowing her to push the boundaries of medicinal chemistry.

Collaborations

Throughout her career, Barbara has collaborated with notable individuals in the field, including Thierry Imbert and Wouter Koek. These partnerships have fostered a collaborative atmosphere that encourages innovation and accelerates the development of transformative healthcare solutions.

Conclusion

Barbara Monse exemplifies the spirit of innovation in the medical research domain. Through her patented inventions, she has demonstrated a commitment to advancing therapeutic approaches for several critical health issues. Her work continues to inspire future generations of inventors and researchers in the field of medicinal chemistry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…